News Headlines

  1. Piramal Pharma Solutions Formalizes Partnership With IntoCell, Expanding Its Payload-Linker Platform And Bioconjugate Capabilities 10/30/2025

    Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has signed a Memorandum of Understanding (MOU) to solidify its strategic partnership and explore potential collaboration opportunities in ADC development with IntoCell Inc. (KOSDAQ: 287840), a leading Korean biotechnology company specializing in innovative antibody-drug conjugate (ADC) linker and payload platform technologies.

  2. SK pharmteco And LOTTE BIOLOGICS Sign Strategic Partnership To Strengthen Global ADC CDMO Capabilities 10/29/2025

    SK pharmteco and LOTTE BIOLOGICS have announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market.

  3. Serán Bioscience Expands Commercial Manufacturing With New 100,000 Sq. Ft. Campus In Bend, Oregon 10/29/2025

    Serán BioScience, LLC, a leading science-driven drug development partner, today announced the completion of two of the three new buildings and commencement of construction of the third facility for of its new 100,000 ft2 commercial manufacturing campus in Bend, Oregon. The new campus will encompass a 50,000 ft2 manufacturing facility, complemented by an adjacent 50,000 ft2 space dedicated to specialized packaging and supply chain operations. The expansion marks a significant milestone in Serán’s mission to provide fully integrated support from first-in-human (FiH) trials through commercial-scale production of small-molecule therapeutics.

  4. Owen Mumford Launches EcoSafe® Safety Syringe Platform – Smarter For Budgets And Kinder To The Planet 10/29/2025

    Oxford - Medical device expert Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.

  5. Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance ERNA-101 Toward Clinical Trials In Ovarian Cancer 10/29/2025

    Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has entered into a collaboration with Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease.

  6. Lilly Announces More Than $1.2B Investment In Puerto Rico Facility To Boost Oral Medicine Manufacturing Capacity In The United States 10/29/2025

    Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.

  7. Wheeler Bio Announces Strategic Partnership With Mitsubishi Corporation To Accelerate Asia-Pacific Business Development 10/29/2025

    Wheeler Bio, a U.S.-based High Science/High Touch contract development and biomanufacturing organization (CDMO), today announced a strategic partnership with Mitsubishi Corporation to expand Wheeler's commercial reach and business development activities across the Asia-Pacific region.

  8. Slingshot Biosciences And Cellares Combine TruCytes Biomarker Controls With The Cell Q Platform To Enhance Quality And Automation In Cell Therapy Manufacturing 10/28/2025

    Slingshot Biosciences, the leader in precision-engineered cell mimic controls, announced a strategic collaboration with Cellares, the first Integrated Development and Manufacturing Organization (IDMO).

  9. Follow The Map Of Pharmaceutical World With PHARMAP 2026 10/28/2025

    The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) 2026 welcomes project leaders, procurement specialists and technical professionals  from the whole value chain. On 20-21 April in Amsterdam, the Congress is set to address evolving trends in pharma industry: sustainable packaging solutions, anti-counterfeit policies and more.

  10. NEOM And WuXi AppTec Sign Strategic MoU To Advance Saudi Arabia's Biotech Sector 10/28/2025

    NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding (MoU) with WuXi AppTec, a leading global pharmaceutical contract research, development and manufacturing organization (CRDMO).